IGF-1/IGFBP-3 ratio has been shown to positively correlate with free IGF-1 [92] and has been associated with a number of clinical outcomes, including functional status in nonagenarians [23], metabolic disease [89,90], and neoplastic diseases [91,93]. The gene discussed is IGFBP3; the disease is Other metabolic disease.